Murphy MJ
AlphaMed Press, Miamisburg, Ohio, 45342-3758, USA.
Oncologist. 1996;1(5):VI.
In northern hemispheres, October heralds the onset of autumn and we are reminded that its cool breezes will soon blow wintry as 1996 draws to a close. Tempus fugit! The swift passage of time also reminds us that the first volume of The Oncologist will soon conclude with its sixth issue in December. However, before 1996 becomes history, let's pause and reflect on the pledges we made to our readership at the beginning of the year. The Founding Editors conceived the Journal to provide authoritative, topical, innovative articles in an attractive format for a very special reader: the busy, practicing physician who cares for cancer patients. Our commitment is to critically review and publish papers designed to interpret the vast amounts of data available to physicians. As the famed radiotherapist and Founding Editor, Eli Glatstein, summarized, "The Oncologist emphasizes the interpretation rather than the data." The Oncologist to date has published more than forty manuscripts from international authorities. The inaugural issue featured, among other highly acclaimed papers, "Locally Advanced Breast Cancer," by Valero, Buzdar and Hortobagyi, and David Kuter's "Thrombopoietin: Biology and Clinical Applications." Fidias, Chabner and Grossbard contributed "Purine Analogs for the Treatment of Low-Grade Lymphoproliferative Disorders" in the next issue, and Pavletic and Armitage proffered an update on "Bone Marrow Transplantation for Cancer." Issue 4 highlighted Jemi Olak and Arthur Ng's "Diagnosis and Management of Early-Stage Non-Small Cell Lung Cancer," as well as "Multimodality Therapy for Esophageal Cancer" by Siewert, Stein and Fink. In this current issue, "Dose Intensity of Chemotherapy for Childhood Cancers," by Smith, Abrams, Trimble and Ungerleider, and "Surgical Sphincter Preservation in Rectal Cancer" by Peter M. Schlag present contemporary and authoritative views of two important clinical topics which also document the Journal's intent to discuss both adult and pediatric cancer care. Our Meet The Professor section is fast becoming a popular feature which attracts comments from readers and responses from the author professor. We call your attention to Professor Barrie R. Cassileth's fascinating article, "Alternative and Complementary Cancer Treatments," and her commentary in this issue. The Physician Education section has presented hematopoiesis through informative and beautifully illustrated papers with texts by distinguished hematologists and molecular biologists. In this issue, we feature the first Patient Care section, From The Bethesda Post, wherein clinical trials and experimental treatments are announced. In cooperation with The Cancer Letter, The Oncologist News Bulletin presents late-breaking news pertinent to the world's cancer care community. With this issue, we have instituted an addition to this section, featuring information from Memorial Sloan-Kettering Cancer Center on a study involving Ashkenazi Jewish women. We urge cancer centers, pharmaceutical and biotechnology companies to avail themselves of this section by sending our editorial office your newsworthy reports. We hope that our readers are benefiting from the Journal and enjoying the art which has graced it. In order to assess how well we are fulfilling our pledges to our readership, we need to hear from you. Tell us how we can make The Oncologist more relevant to your medical practice. We promise to share your comments with our Editorial Board to further enhance the Journal. In so doing, we will draw closer to fulfilling our pledge to you, our readers.
在北半球，十月预示着秋天的来临，这也让我们意识到，随着1996年接近尾声，凉爽的秋风很快就会带来冬日的寒意。光阴似箭！时光的飞逝也提醒我们，《肿瘤学家》第一卷即将随着12月的第六期出版而结束。然而，在1996年成为历史之前，让我们停下来反思一下年初我们对读者做出的承诺。创刊编辑创办这本杂志的目的是，以一种有吸引力的形式为一类非常特殊的读者——忙碌的、治疗癌症患者的执业医生——提供权威、热门、新颖的文章。我们的承诺是严格评审并发表旨在解读医生可获取的大量数据的论文。正如著名放射治疗师兼创刊编辑伊莱·格拉茨坦总结的那样：“《肿瘤学家》强调的是解读而非数据。”到目前为止，《肿瘤学家》已经发表了四十多篇来自国际权威人士的稿件。创刊号刊登了众多广受赞誉的论文，其中包括瓦莱罗、布兹达尔和霍尔托巴吉撰写的《局部晚期乳腺癌》，以及大卫·库特的《血小板生成素：生物学与临床应用》。在下一期中，菲迪亚斯、查布纳和格罗斯巴德撰写了《嘌呤类似物治疗低度淋巴增殖性疾病》，帕夫莱蒂克和阿米蒂奇提供了《癌症的骨髓移植》的最新情况。第四期重点介绍了杰米·奥拉科和亚瑟·吴的《早期非小细胞肺癌的诊断与治疗》，以及西韦特、施泰因和芬克撰写的《食管癌的多模式治疗》。在本期中，史密斯、艾布拉姆斯、特里姆布尔和昂格尔莱德撰写的《儿童癌症化疗的剂量强度》，以及彼得·M·施拉格撰写的《直肠癌的保留括约肌手术》，呈现了两个重要临床话题的当代权威性观点，这也证明了该杂志讨论成人和儿童癌症治疗的意图。我们的“与教授面对面”栏目正迅速成为一个受欢迎的特色板块，吸引了读者的评论和作者教授的回应。我们提请您关注巴里·R·卡西莱特教授的精彩文章《替代和补充癌症治疗》以及她在本期的评论。“医生教育”板块通过杰出血液学家和分子生物学家撰写的内容丰富、插图精美的论文介绍了造血过程。在本期中，我们推出了首个“患者护理”板块，来自贝塞斯达邮报，其中公布了临床试验和实验性治疗方法。与《癌症通讯》合作，《肿瘤学家新闻简报》提供与全球癌症护理界相关的最新消息。在本期中，我们在这个板块新增了内容——介绍纪念斯隆凯特琳癌症中心一项涉及德系犹太女性的研究的信息。我们敦促癌症中心、制药和生物技术公司向我们的编辑部发送有新闻价值的报告，利用这个板块。我们希望读者能从这本杂志中受益，并欣赏为其增色的艺术内容。为了评估我们在履行对读者的承诺方面做得如何，我们需要听取您的意见。告诉我们如何让《肿瘤学家》与您的医疗实践更相关。我们承诺会与编辑委员会分享您的意见，以进一步提升这本杂志。这样做，我们将更接近履行对您——我们的读者的承诺。
